KG&L Capital Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.43M | Sell |
1,195
-3
| -0.3% | -$3.06K | 0.85% | 31 |
|
|
2026
Q1 | $1.1M | Sell |
1,198
-2,940
| -71% | -$2.98M | 0.79% | 36 |
|
|
2025
Q4 | $4.45M | Sell |
4,138
-188
| -4% | -$180K | 1.1% | 21 |
|
|
2025
Q3 | $3.3M | Sell |
4,326
-3,257
| -43% | -$2.42M | 0.88% | 27 |
|
|
2025
Q2 | $5.91M | Buy |
7,583
+2,683
| +55% | +$2.08M | 1.74% | 12 |
|
|
2025
Q1 | $4.05M | Sell |
4,900
-343
| -7% | -$285K | 1.31% | 18 |
|
|
2024
Q4 | $4.05M | Buy |
5,243
+510
| +11% | +$422K | 1.3% | 17 |
|
|
2024
Q3 | $4.19M | Buy |
4,733
+182
| +4% | +$164K | 1.35% | 17 |
|
|
2024
Q2 | $4.12M | Buy |
4,551
+40
| +0.9% | +$32K | 1.43% | 16 |
|
|
2024
Q1 | $3.51M | Buy |
4,511
+94
| +2% | +$66.9K | 1.39% | 17 |
|
|
2023
Q4 | $2.57M | Buy |
4,417
+878
| +25% | +$512K | 1.08% | 20 |
|
|
2023
Q3 | $1.9M | Sell |
3,539
-1,905
| -35% | -$982K | 0.92% | 23 |
|
|
2023
Q2 | $2.55M | Sell |
5,444
-1,345
| -20% | -$564K | 1.22% | 18 |
|
|
2023
Q1 | $2.33M | Buy |
6,789
+3,194
| +89% | +$1.08M | 1.22% | 19 |
|
|
2022
Q4 | $1.32M | Sell |
3,595
-2,834
| -44% | -$1M | 0.76% | 30 |
|
|
2022
Q3 | $2.08M | Buy |
6,429
+375
| +6% | +$119K | 1.17% | 24 |
|
|
2022
Q2 | $1.96M | Sell |
6,054
-207
| -3% | -$62.1K | 1.06% | 25 |
|
|
2022
Q1 | $1.79M | Buy |
6,261
+619
| +11% | +$159K | 0.75% | 37 |
|
|
2021
Q4 | $1.56M | Buy |
5,642
+469
| +9% | +$119K | 0.63% | 43 |
|
|
2021
Q3 | $1.2M | Buy |
5,173
+860
| +20% | +$212K | 0.52% | 53 |
|
|
2021
Q2 | $990K | Buy |
4,313
+386
| +10% | +$77.5K | 0.45% | 59 |
|
|
2021
Q1 | $734K | Buy |
3,927
+319
| +9% | +$62.4K | 0.37% | 62 |
|
|
2020
Q4 | $609K | Sell |
3,608
-6,498
| -64% | -$970K | 0.33% | 73 |
|
|
2020
Q3 | $1.5M | Buy |
10,106
+8,128
| +411% | +$1.26M | 0.94% | 28 |
|
|
2020
Q2 | $324K | Buy |
+1,978
| New | +$304K | 0.25% | 74 |
|
|
2020
Q1 | – | Sell |
-7,887
| Closed | -$1.04M | – | 96 |
|
|
2019
Q4 | $1.04M | Buy |
7,887
+1,753
| +29% | +$203K | 0.88% | 35 |
|
|
2019
Q3 | $685K | Buy |
6,134
+1,425
| +30% | +$159K | 0.62% | 42 |
|
|
2019
Q2 | $521K | Sell |
4,709
-196
| -4% | -$23.1K | 0.5% | 54 |
|
|
2019
Q1 | $636K | Sell |
4,905
-1,332
| -21% | -$162K | 0.64% | 48 |
|
|
2018
Q4 | $722K | Buy |
+6,237
| New | +$697K | 0.81% | 38 |
|
Other funds holding LLY
KG&L Capital Management's LLY Position: Q2 2026 in Review
KG&L Capital Management reduced its Eli Lilly (LLY) stake by 0.25% in Q2 2026, selling an estimated $3.06K and leaving 1,195 shares worth $1.43M. The position accounts for 0.85% of the portfolio, ranked #31.
KG&L Capital Management first reported a position in LLY in Q4 2018 and has held it in 30 quarters since. The position peaked at $5.91M in Q2 2025. 4,633 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- KG&L Capital Management held 1,195 shares of Eli Lilly worth $1.43M as of Q2 2026.
- KG&L Capital Management sold 3 Eli Lilly shares in Q2 2026, an estimated $3.06K.
- Eli Lilly made up 0.85% of KG&L Capital Management's portfolio in Q2 2026, its #31 holding.
- KG&L Capital Management first reported a position in Eli Lilly in Q4 2018 and has held it in 30 quarters since.
- KG&L Capital Management's Eli Lilly position peaked at $5.91M in Q2 2025.
- 4,633 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on KG&L Capital Management's 13F filing for Q2 2026, filed 7 Aug 2026.